|
*Ferraz et al., 2014 São Paulo State, Brazil
|
13.8
|
Dif BCVA ≥ 0.15 - NCVA ≥ 0.15
|
6.5
|
Dif BCVA > 0.5 - NCVA > 0.5)
|
9.8
|
1.3 ≤ VA < 0.5
|
4.1
|
VA < 1.3
|
|
Ramke et al., 2012 [19] Timor-Leste, Afrique
|
3.7
|
NCVA < 6/18 ≥ 6/18 with pinhole
|
9.6
|
VA < 20/40 Enhancement 2 lines
|
-
|
-
|
-
|
-
|
|
Brian et al., 2011 [18] Figi, Japan
|
10.3
|
Presenting corrected vision ≥ 6/18
|
4.8
| | | | | |
|
Uribe et al., 2011 [9] Tucson/Nogales, USA
|
22.57
|
Enhancement 2 lines
| | | | | | |
|
Barnes et al., 2011 [21] Ta’u Island, Samoa, USA
|
-
|
-
|
-
|
-
|
10.5
|
6/60 ≤ VA < 6/18
|
4.8
|
VA < 6/60
|
|
Schellini et al., 2009 [12] Botucatu Eye Study, Brazil
|
-
|
-
|
5.5
|
Dif BCVA ≥ 20/60 -NCVA ≥ 20/60)
|
5.2
|
20/400 ≤ VA < 20/60
|
2.2
|
VA <20/400
|
|
Varma et al., 2008 [16] La Puente, California
|
15.1
|
Enhancement 2 lines
|
8.9
|
Dif BCVA ≥ 20/40 - NCVA ≥ 20/40)
|
-
|
-
|
-
|
-
|
|
Ntim-Amponsah, 2007 [15] Gana, Afrique
|
11.9
|
Enhancement 2 lines
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Ramke et al., 2007 [17] Timor-Leste, Afrique
|
-
|
-
|
11.7
|
Dif BCVA ≥ 6/18 - NCVA ≥ 6/18)
|
-
|
6/60 ≤ VA < 6/18
|
-
|
VA < 6/60
|
|
Dandona et al., 2002 [20] Andhra Pradesh, Índia
|
-
|
-
|
4.49
|
Dif BCVA ≥ 6/12 - NCVA ≥ 6/12)
|
-
|
VA < 6/12
|
-
|
-
|
|
Thiagalingam et al., 2002 [11] Blue Montains, Australia
|
10.2
|
VA < 6/9 Enhancement 2 lines
|
-
|
-
|
-
|
-
|
-
|
-
|
